SURI - Simplify Propel Opportunities ETF (USD) (US82889N6242)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen

Speichern Schließen

(%)

US82889N6242

SURI ISIN

Exchange Traded Funds (ETF)

Fondstyp

Simplify Asset Management

Anbieter

NAV pro Aktie

07/02/2023

Startdatum

4 Wiederholungen pro Jahr

Ausschüttung von Dividenden

CEOJLS

CFI

SURI

Ticker

Formed

Status

Equity

Investitionsobjekt

Healthcare

Sektor

Global

Geographie

No benchmark

Benchmark

2.54 %

Gesamtkostenquote

Physical

Replikationsmethode

74,35 Mio. USD

Gesamtes Fondsvermögen | 26/06/2026

74,35 Mio. USD

Aktien-Anlageklasse Volumen | 26/06/2026

Nein

UCITS

Rendite auf 26/06/2026, NYSE Arca

YTD

8,97 %
1M

1,21 %
3M

10,28 %
6M

13,52 %
1J

42,77 %
3J

20,88 %
5J

-
10J

-

Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum

Zum Vergleichen hinzufügen

Kurse (SURI)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

Fund profile

The Simplify Propel Opportunities ETF is an actively managed ETF that seeks long-term capital appreciation by investing in a portfolio comprised primarily of global biotech, pharma, health care technology, and life science companies

SURI profile

The Simplify Propel Opportunities ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The Simplify Asset Management fund’s base currency is USD and the share class was registered 07.02.2023 with unique ISIN - US82889N6242. Main exchange is NYSE Arca and ticker symbol is SURI. The total expense ratio is 2.54%. The Simplify Propel Opportunities ETF (USD) pays dividends 4 time(s) per year.

Struktur SURI auf 25/06/2026

Struktur in Excel herunterladen

Wertpapier	Wertpapier
PLAINS GP HLDGS L P	41,41%
ACHIEVE LIFE SCIENCES INC USD 0.001	11,29%
MILESTONE PHARMACEUTICALS INC NPV	5,79%
DELCATH SYS INC USD 0.01	4,45%
CORCEPT THERAPEUTICS INC USD 0.001	4,43%
ABEONA THERAPEUTICS INC USD 0.01	3,8%
ACHIEVE LIFE SCIENCES I WTS 30JUN30	3,61%
PHATHOM PHARMACEUTICALS USD 0.0001	3,57%
CELLDEX THERAPEUTICS INC USD 0.001	2,78%
COMPASS PATHWAYS PLC USD 0.008 ADR	2,15%
KYVERNA THERAPEUTICS IN USD 0.00001	2,07%
LEONABIO INC USD 0.0001	1,79%
ZEVRA THERAPEUTICS INC USD 0.0001	1,76%
AQUESTIVE THERAPEUTICS IN USD 0.001	1,72%
PALISADE BIO INC USD 0.01	1,6%
INVENTIVA SA NPV ADR	1,52%
Telesat, 5.625% 6dec2026, USD	1,24%
ARTIVA BIOTHERAPEUTICS I USD 0.0001	1,24%
ORCHESTRA BIOMED HLDGS I USD 0.0001	1,18%
OCULAR THERAPEUTIX INC USD 0.0001	1,09%
IMMUNIC INC USD 0.0001	0,91%
EYEPOINT INC	0,86%
SAB BIOTHERAPEUTICS INC USD 0.0001	0,8%
ACHIEVE LIFE SCIENCES WTS	0,75%
AKERO THERAPEUTICS INC CVR	0,59%
UPSTREAM BIO INC USD 0.001	0,55%
OVID THERAPEUTICS INC USD 0.001	0,32%
Chinook Therapeutics, ord.	0%
EIGER BIOPHARMACEUTICALS USD 0.0001	0%
WTS - MILESTONE PHARMACEUTICALS INC SERIES B	0%
JASPER THERAPEUTIC WTS	0%
WTS - TENAYA THERAPEUTICS INC	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series I	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series H	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series J	0%
ALTIMMUNE INC	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series K	0%
Cash	-3,29%

Alle anzeigen Verstecken

Andere - %